JP2012012402A5 - - Google Patents

Download PDF

Info

Publication number
JP2012012402A5
JP2012012402A5 JP2011178577A JP2011178577A JP2012012402A5 JP 2012012402 A5 JP2012012402 A5 JP 2012012402A5 JP 2011178577 A JP2011178577 A JP 2011178577A JP 2011178577 A JP2011178577 A JP 2011178577A JP 2012012402 A5 JP2012012402 A5 JP 2012012402A5
Authority
JP
Japan
Prior art keywords
antibody
binding
antigen
fragment
gpr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011178577A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012012402A (ja
JP5933204B2 (ja
Filing date
Publication date
Priority claimed from US09/266,464 external-priority patent/US6329159B1/en
Application filed filed Critical
Publication of JP2012012402A publication Critical patent/JP2012012402A/ja
Publication of JP2012012402A5 publication Critical patent/JP2012012402A5/ja
Application granted granted Critical
Publication of JP5933204B2 publication Critical patent/JP5933204B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011178577A 1999-03-11 2011-08-17 抗gpr−9−6および抗teck抗体ならびにgpr−9−6およびteckの機能の調節因子の同定方法 Expired - Lifetime JP5933204B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/266,464 US6329159B1 (en) 1999-03-11 1999-03-11 Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
US09/266,464 1999-03-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000604070A Division JP5112578B2 (ja) 1999-03-11 2000-03-10 抗gpr−9−6および抗teck抗体ならびにgpr−9−6およびteckの機能の調節因子の同定方法。

Publications (3)

Publication Number Publication Date
JP2012012402A JP2012012402A (ja) 2012-01-19
JP2012012402A5 true JP2012012402A5 (enExample) 2012-10-11
JP5933204B2 JP5933204B2 (ja) 2016-06-08

Family

ID=23014693

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000604070A Expired - Lifetime JP5112578B2 (ja) 1999-03-11 2000-03-10 抗gpr−9−6および抗teck抗体ならびにgpr−9−6およびteckの機能の調節因子の同定方法。
JP2011178577A Expired - Lifetime JP5933204B2 (ja) 1999-03-11 2011-08-17 抗gpr−9−6および抗teck抗体ならびにgpr−9−6およびteckの機能の調節因子の同定方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000604070A Expired - Lifetime JP5112578B2 (ja) 1999-03-11 2000-03-10 抗gpr−9−6および抗teck抗体ならびにgpr−9−6およびteckの機能の調節因子の同定方法。

Country Status (7)

Country Link
US (6) US6329159B1 (enExample)
EP (1) EP1157043B2 (enExample)
JP (2) JP5112578B2 (enExample)
AT (1) ATE517123T1 (enExample)
AU (1) AU771603B2 (enExample)
CA (1) CA2365230C (enExample)
WO (1) WO2000053635A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU765142B2 (en) * 1998-06-01 2003-09-11 Ortho-Mcneil Pharmaceutical, Inc. Method for treating neurodegenerative disorders
US20050100548A1 (en) * 2001-07-24 2005-05-12 Biogen Idec Ma Inc. BAFF, inhibitors thereof and their use in the modulation of B-cell response
US6329159B1 (en) * 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
US6698636B2 (en) * 2000-09-28 2004-03-02 June Angus Waist pouch
US7468253B2 (en) * 2001-06-07 2008-12-23 Chemocentryx, Inc. Method for multiple chemokine receptor screening for antagonists using RAM assay
ATE347695T1 (de) * 2001-06-07 2006-12-15 Chemocentryx Inc Zellwanderungsassay
NO20013192L (no) * 2001-06-25 2002-12-27 Medinnova As Metode for monitering av T-celler
US7253007B2 (en) * 2001-11-30 2007-08-07 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7413866B2 (en) * 2001-11-30 2008-08-19 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7871619B2 (en) * 2001-11-30 2011-01-18 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7442512B2 (en) * 2001-11-30 2008-10-28 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
WO2003095967A2 (en) * 2002-05-14 2003-11-20 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
MXPA04011465A (es) 2002-05-24 2005-02-14 Millennium Pharm Inc Inhibidores de ccr9 y metodos de uso de los mismos.
US20120135415A1 (en) * 2002-11-15 2012-05-31 Morehouse School Of Medicine Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies
AU2003294290A1 (en) * 2002-11-15 2004-06-15 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
US9233120B2 (en) 2002-11-15 2016-01-12 Jyant Technologies Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration
WO2004045526A2 (en) * 2002-11-15 2004-06-03 Morehouse School Of Medicine Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
US8512701B2 (en) * 2002-11-15 2013-08-20 Morehouse School Of Medicine Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration
US8658377B2 (en) 2002-11-15 2014-02-25 Morehouse School Of Medicine Detecting cancer with anti-CCL25 and anti-CCR9 antibodies
EP1606251B1 (en) * 2002-12-20 2009-04-08 ChemoCentryx Inc Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
SG173919A1 (en) 2003-04-23 2011-09-29 Medarex Inc Compositions and methods for the therapy of inflammatory bowel disease
US20100247540A1 (en) * 2003-10-30 2010-09-30 Chemocentryx, Inc. Methods and Compositions For Modulating Angiogenesis
BRPI0509419A (pt) * 2004-04-16 2007-09-04 Genentech Inc método de ensaio imunossorvente ligado por enzimas, anticorpos, hibridoma e kit de imunoensaio
EP2662390B1 (en) 2004-06-21 2017-08-02 E. R. Squibb & Sons, L.L.C. Interferon alpha receptor 1 antibodies and their uses
AU2006238855B2 (en) * 2005-04-21 2011-12-22 Chemocentryx, Inc. Reagents that bind CCX-CKR2
CN104797933A (zh) 2012-09-07 2015-07-22 阿尔伯达大学董事会 用于诊断发炎性肝病的方法和组合物
EP2876114A1 (en) * 2013-11-25 2015-05-27 Consejo Superior De Investigaciones Científicas Antibodies against CCR9 and applications thereof
EP3416641A1 (en) 2016-02-16 2018-12-26 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Modulators of ccr9 for treating tumor resistance to immune responses
EP3416640A1 (en) 2016-02-16 2018-12-26 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Modulators of tumor immune resistance for the treatment of cancer
JP2020513554A (ja) 2016-12-07 2020-05-14 プロジェニティ, インコーポレイテッド 胃腸管の検出方法、装置およびシステム
WO2018112264A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
CA3120619A1 (en) 2018-11-19 2020-05-28 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
EP4309722A3 (en) 2019-12-13 2024-08-07 Biora Therapeutics, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
EP4472741A1 (en) 2022-02-03 2024-12-11 SunRock Biopharma S.L. Combination therapy comprising anti-ccr9 antibody and vincristine for cancer
JP7368678B1 (ja) 2023-04-26 2023-10-25 イミュニティリサーチ株式会社 Cd4+t細胞集団中の特定の細胞亜集団の相対量の測定方法
EP4578874A1 (en) * 2023-12-29 2025-07-02 SunRock Biopharma S.L. Anti-ccr9 antibody

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US18167A (en) * 1857-09-08 Improvement in blast-furnaces
US5440021A (en) * 1991-03-29 1995-08-08 Chuntharapai; Anan Antibodies to human IL-8 type B receptor
US5652133A (en) 1993-01-28 1997-07-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloning and expression of the human macrophage inflammatory protein-1.alpha.α) /rantes receptor
WO1997032019A2 (en) * 1996-03-01 1997-09-04 Euroscreen S.A. C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses
IL127551A0 (en) 1996-06-17 1999-10-28 Human Genome Sciences Inc Chemokine beta-15
US5981231A (en) 1996-06-17 1999-11-09 Human Genome Sciences, Inc. Polynucleotides encoding chemokine β-15
US6723520B2 (en) 1996-07-05 2004-04-20 Schering Corporation Antibodies that bind chemokine teck
AU3574997A (en) 1996-07-05 1998-02-02 Schering Corporation Mammalian chemokine reagents
ATE360689T1 (de) * 1996-09-10 2007-05-15 Kocher Theodor Inst Cxcr3 chemokine rezeptor, antikoerper, nukleinsaeure und deren verfahren zur anwendung
WO1998032858A2 (en) 1997-01-23 1998-07-30 Schering Corporation Mammalian chemokines; receptors; reagents; uses
EP0878542A3 (en) * 1997-04-22 2000-04-19 Smithkline Beecham Corporation cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
EP1019502A2 (en) * 1997-08-06 2000-07-19 Regeneron Pharmaceuticals, Inc. Human orphan receptor ntr-1
US6329159B1 (en) 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
YU78601A (sh) * 1999-05-05 2005-07-19 Aventis Pharma Deutschland Gmbh. 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže
WO2001049325A2 (en) * 2000-01-07 2001-07-12 Stichting Klinische Farmacologie Groningen Gene therapy to promote angiogenesis and/or the treatment of heart failure
ATE517102T1 (de) 2002-11-18 2011-08-15 Chemocentryx Inc Arylsulfonamide

Similar Documents

Publication Publication Date Title
JP2012012402A5 (enExample)
US11685789B2 (en) CD47 antigen-binding molecules
CN109843927B (zh) 抗b7-h3抗体、其抗原结合片段及其医药用途
JP2012501669A5 (enExample)
JP2018511319A5 (enExample)
JP2019532619A5 (enExample)
TW201837056A (zh) B7-h3抗體、其抗原結合片段及其醫藥用途
JP2014518883A5 (enExample)
JP2012501670A5 (enExample)
JP2013506428A5 (enExample)
JP2010533498A5 (enExample)
JP2014518615A5 (enExample)
JP2014111644A5 (enExample)
WO2014089209A2 (en) Blood-brain barrier (bbb) penetrating dual specific binding proteins
JP2014524733A5 (enExample)
US11136411B2 (en) Method for the treatment or prevention of a disease related to vascular endothelial lipase by administering a humanized monoclonal antibody
JP2013539369A5 (enExample)
JP2018518151A5 (enExample)
JP2005528914A5 (enExample)
CN117062834A (zh) Gpc3人源化抗体及其应用
CN113227148B (zh) 抗gpc3抗体、其抗原结合片段及其医药用途
JP2015508056A5 (enExample)
CN112094348B (zh) 抗人Tim3抗体或其功能性片段及其应用
WO2019086574A1 (en) Cd47 and cd33 antigen-binding molecules
CA3120059A1 (en) Anti-periostin antibodies and uses thereof